Article Text
Learning from errors
A case report of neuroleptic malignant syndrome
Summary
A 32-year-old male patient with a history of treatment resistant paranoid schizophrenia developed neuroleptic malignant syndrome (NMS) during changeover of his antipsychotic medication from zuclopenthixol depot to clozapine. This case highlights the difficulties of cross-tapering two antipsychotics—that is, converting from a typical depot medication to an oral atypical antipsychotic.
Statistics from Altmetric.com
Footnotes
Competing interests: none.
Patient consent: Patient/guardian consent was obtained for publication